Morepen Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 395.38 | 385.08 | 408.13 |
| Operating Expense | 372.33 | 351.78 | 371.68 |
| Net Profit | 8.06 | 11.91 | 22.69 |
| Net Profit Margin | 2.04 | 3.09 | 5.56 |
| Earning Per Share | 0.15 | 0.20 | 0.41 |
| EBIDTA | 23.04 | 28.57 | 36.46 |
| Effective Tax Rate | 14.28 | 2.01 | 21.10 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 395.38 |
| Operating Expense | 372.33 |
| Net Profit | 8.06 |
| Net Profit Margin | 2.04 |
| Earning Per Share | 0.15 |
| EBIDTA | 23.04 |
| Effective Tax Rate | 14.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,554.54 | 1,537.59 | 1,338.88 |
| Operating Expenses Annual | 1,401.12 | 1,375.77 | 1,261.61 |
| Operating Profit Annual | 169.13 | 174.38 | 83.03 |
| Interest Annual | 7.10 | 3.51 | 1.98 |
| Depreciation | 24.44 | 21.90 | 12.03 |
| Net Profit Annual | 101.58 | 110.94 | 46.24 |
| Tax Annual | 36.01 | 38.04 | 16.80 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,554.54 |
| Operating Expenses Annual | 1,401.12 |
| Operating Profit Annual | 169.13 |
| Interest Annual | 7.10 |
| Depreciation | 24.44 |
| Net Profit Annual | 101.58 |
| Tax Annual | 36.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 15.30 | 21.26 | 15.38 |
| Cash Flow from Operations | 29.08 | 77.36 | -102.12 |
| Cash Flow from Investing | -280.42 | -83.60 | -36.20 |
| Cash Flow from Financing | 260.47 | 0.28 | 144.20 |
| Cash Flow at the End | 24.43 | 15.30 | 21.26 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 15.30 |
| Cash Flow from Operations | 29.08 |
| Cash Flow from Investing | -280.42 |
| Cash Flow from Financing | 260.47 |
| Cash Flow at the End | 24.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 10.88 | 11.34 | 6.20 |
| PBIT Margin (%) | 9.31 | 9.92 | 4.86 |
| PBT Margin (%) | 8.00 | 7.09 | 2.41 |
| Net PROFIT Margin (%) | 6.53 | 7.22 | 3.45 |
| Return On Networth / Equity (%) | 9.81 | 13.29 | 6.71 |
| Return On Networth /Employed (%) | 12.79 | 17.08 | 8.78 |
| Return On Assets (%) | 8.95 | 12.41 | 6.25 |
| Total Debt / Equity (X) | 0.06 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 1.37 | 1.72 | 1.81 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 10.88 |
| PBIT Margin (%) | 9.31 |
| PBT Margin (%) | 8.00 |
| Net PROFIT Margin (%) | 6.53 |
| Return On Networth / Equity (%) | 9.81 |
| Return On Networth /Employed (%) | 12.79 |
| Return On Assets (%) | 8.95 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 1.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 365.87 | 216.54 | 170.82 |
| Total Current Assets Annual | 1,106.78 | 842.91 | 730.85 |
| Non Current Assets Annual | 614.42 | 436.40 | 374.69 |
| Total Shareholders Funds Annual | 1,181.50 | 889.02 | 780.11 |
| Total Assets Annual | 1,721.20 | 1,279.31 | 1,105.54 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 365.87 |
| Total Current Assets Annual | 1,106.78 |
| Non Current Assets Annual | 614.42 |
| Total Shareholders Funds Annual | 1,181.50 |
| Total Assets Annual | 1,721.20 |
EPS (INR)
Expected
0.20
Reported
0.20
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -5.41%
Sep 2024
EPS beaten by 0.00%
